SHARE

Syngenta commits $120m to new UK bioscience hub amid pharma pullback

The Chinese-owned agtech group will build the BioStar research centre at Jealott’s Hill, citing the UK’s agricultural innovation and science-based regulation. Syngenta says the purely commercial investment contrasts with drugmakers delaying projects.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.